Canadian Pharmacy Blog

Abilify (Aripiprazole) is considered to be an effective antipsychotic medication for treating schizophrenia disease and Bipolar I Disorder. The drug is developed by two partnered companies: Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company.
They announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) [...]

It is known that Zyprexa (Olanzapine) drug is effective in treating of schizophrenia, acute mixed and manic episodes of bipolar I disorder. This medicine is widely prescribed for adults in the United States.
However, there are some cases to be cautious taking Olanzapine tablets.
First, this kind of schizophrenia medication is not approved for the [...]

Seroquel (Quetiapine) (original formulation) is considered to be a well-known prescribed atypical antipsychotic medicine in the United States. In October 2006 it was approved in the US by the FDA for the treatment of bipolar manic depression. By the way, another form, Quetiapine drug sustained release [...]

Taro Iwamoto, Ph.D., Chief Executive Officer, President and Chief Operating Officer, Otsuka Pharmaceutical Development and Commercialization, Inc. stated that they are very pleased to receive expanded indications on the use of Abilify (Aripiprazole) in pediatric patients (aged 10-17) and adolescents.
In fact, The FDA first approved ABILIFY antipsychotic medicine for the treatment of [...]

In a class of antipsychotic drugs generic Lexapro is a useful treatment option for treating depression. A new study was conducted and Forest Laboratories, Inc., (NYSE: FRX) today announced the results.
The randomized, double-blinded study involved patients 18-80 years of age with DSM-IV diagnosed MDD as determined by a Montgomery-Asberg Depression Rating Scale (MADRS) score of [...]

It has been known today that generic Singulair is effective in preventing exercise-induced bronchoconstriction (EIB). According to the update facts by Merck & Co., Inc. a new indication is useful in patients aged 15 years and older.
The efficacy of SINGULAIR 10 mg was investigated in three randomized, double-blind, placebocontrolled crossover studies in 160 patients aged [...]